Bridging the Gap: R&D and GMP Integration for Pharmaceutical Innovation
Author: M. Elena Laguardia In the CDMO biotech landscape, translating [...]
Diatheva: Then and Now
Author: Mauro Magnani I founded Diatheva in 2002, in collaboration [...]
The Development of Biological Drugs
Authors: Valentina Fiori, Tomas di Mambro Modern medicine has witnessed [...]
Diatheva: Pioneering Recombinant Protein Solutions for Advanced Biotechnology
Author: Francesco Collacchi Recombinant proteins stand as one of the [...]
Monoclonal Antibodies: The Key Players in targeted therapy
Author: Tomas Di Mambro Antibodies, also known as immunoglobulins, are [...]
New Perspectives for Treating Chronic Lymphocytic Leukemia: The Role of scFvB1IL15
Author: Diego Moricoli A recent study published in Biomolecules by [...]
Understanding CDMOs
Author: Lisa Pucci In the complex world of pharmaceutical development, [...]
Diatheva: Committed to Veterinary Diagnostics as a Member of the International Organization “Diagnostics for Animals (D4A)”
Author: Enrica Omiccioli Diagnostics for Animals is an international organization [...]
The One Health Approach to combat zoonoses: the importance of control strategies, diagnosis, and treatment
Author: Elisa Carloni Zoonoses, diseases that are naturally transmissible from [...]
Highlights AACR IO Conference February 23-26
Author: Diego Moricoli The AACR (American Association Cancer Research) [...]